Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional Results available

A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer

ClinicalTrials.gov ID: NCT02152631

Public ClinicalTrials.gov record NCT02152631. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 12:08 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

JUNIPER: A Randomized Phase 3 Study of Abemaciclib Plus Best Supportive Care Versus Erlotinib Plus Best Supportive Care in Patients With Stage IV NSCLC With a Detectable KRAS Mutation Who Have Progressed After Platinum-Based Chemotherapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main purpose of this study is to evaluate how safe and effective the study drug known as abemaciclib is in participants with lung cancer.

Study identification

NCT ID
NCT02152631
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
453 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 3, 2014 (Actual)
Primary completion
Sep 15, 2017 (Actual)
Completion
Dec 2026 (Estimated)
Last update posted
Feb 6, 2026

2014 – 2026

United States locations

U.S. sites
54
U.S. states
29
U.S. cities
42
Facility City State ZIP Site status
Highlands Oncology Group Fayetteville Arkansas 72703 —
St. Bernards Medical Center Jonesboro Arkansas 72401 —
City of Hope National Medical Center Duarte California 91010 —
University of California - San Diego La Jolla California 92037 —
Loma Linda University School of Medicine Loma Linda California 92350 —
CBCC Global Research, Inc. Los Angeles California 90024 —
Central Coast Medical Oncology Corporation Los Angeles California 90024 —
Fort Wayne Oncology & Hematology Los Angeles California 90024 —
SMO TRIO -Translational Research Los Angeles California 90024 —
St. Joseph Heritage Medical Group Los Angeles California 90024 —
UCLA Department of Medicine-Hematology/Oncology Los Angeles California 90024 —
Cancer Care Associates Medical Group Los Angeles California 90095 —
Dignity Health Care Institute Sacramento California 95816 —
Alegent Immanuel Cancer Center Englewood Colorado 80112 —
Jewish Hospital Englewood Colorado 80112 —
Oncology Hematology West Englewood Colorado 80112 —
SMO Catholic Health Initiatives Englewood Colorado 80112 —
St Joseph Cancer Center Englewood Colorado 80112 —
St. Francis Medical Center Englewood Colorado 80112 —
Medical Oncology Hematology Consultants Newark Delaware 19713 —
Boca Raton Regional Hospital Boca Raton Florida 33486 —
Halifax Medical Center Daytona Beach Florida 32114 —
Memorial Cancer Institute Pembroke Pines Florida 33028 —
H Lee Moffitt Cancer Center Tampa Florida 33612-9497 —
University Cancer & Blood Center, LLC Athens Georgia 30607 —
Ingalls Memorial Hospital Harvey Illinois 60426 —
Indiana University School of Medicine Indianapolis Indiana 46202 —
University of Iowa Iowa City Iowa 52242 —
Cancer Center of Kansas, P.A. Wichita Kansas 67214 —
Central Baptist Hospital Lexington Kentucky 40503 —
University of Louisville Louisville Kentucky 40202 —
Walter Reed National Military Medical Center Bethesda Maryland 20889 —
Metro-West and Greater Boston CNS Research Framingham Massachusetts 01701 —
Karmanos Cancer Institute Detroit Michigan 48201 —
Mercy Medical Research Institute Springfield Missouri 65807 —
Billings Clinic Research Center Billings Montana 59101 —
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756 —
Broome Oncology Johnson City New York 13790 —
Weill Cornell Medical College New York New York 10065 —
Oncology Hematology Care Inc Cincinnati Ohio 45242 —
Oklahoma Cancer Specialists & Research Institute, LLC Tulsa Oklahoma 74146 —
Providence Cancer Center Oncology Hematology Care Portland Oregon 97213 —
UPMC Hillman Cancer Center Pittsburgh Pennsylvania 15213 —
Roper St. Francis Healthcare Charleston South Carolina 29401 —
Chattanooga Oncology Hematology Associates Chattanooga Tennessee 37404 —
Chattanooga Oncology Hematology Associates Nashville Tennessee 37203 —
Tennessee Oncology PLLC Nashville Tennessee 37203 —
Mary Crowley Cancer Research Center Dallas Texas 75230 —
Utah Cancer Specialists Salt Lake City Utah 84106 —
University of Vermont Medical Center Burlington Vermont 05401 —
Virginia Commonwealth University Richmond Virginia 23298 —
Kadlec Clinical Hematology & Oncology Kennewick Washington 99336 —
Swedish Medical Center Seattle Washington 98104 —
Cancer Care Northwest Valley Washington 99216 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 177 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02152631, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 6, 2026 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02152631 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →